SQ-3370

N/A

Report date: 2025/11/15 20:00:09

Base Information

Drug NameSQ-3370

Drug Alias NameSQ3370SQ-3370SQL70/SQP33SQL-70/SQP-33

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Doxorubicin payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors

TargetsDNATopoisomerase II

Therapy Area/IndicationsSarcomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsYes

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesShasqi Inc

China Registration ClassN/A

Develop Information

Active CompaniesShasqi Inc

Inactive CompaniesN/A

Active IndicationsSarcoma

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A